Transcription factor Sp1 is involved in expressional regulation of coxsackie and adenovirus receptor in cancer cells

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Chung, Sun Ku ^a,b   Kim, Joo Young ^a,c   Lim, Joong Yeon ^a   Park, Young Mi ^a   Hwang, Ha Young ^a   Nam, Jae Hwan ^d   Park, Sang Ick ^a  

^a Korea National Institute of Health   (South Korea)

^b SECTION OF MOLECULAR BIOLOGY   (United States)

^c Korea University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; HISTONE DEACETYLASE INHIBITOR; TRANSCRIPTION FACTOR SP1; CXADR LIKE MEMBRANE PROTEIN; CXADR-LIKE MEMBRANE PROTEIN; TUMOR SUPPRESSOR PROTEIN; VIRUS RECEPTOR;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; WILD TYPE; BIOSYNTHESIS; CELL STRAIN HEPG2; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PATHOLOGY;

ADENOVIRIDAE;

GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; NEOPLASMS; RECEPTORS, VIRUS; RESPONSE ELEMENTS; SP1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 84855560254     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/636497     Document Type: Article

References (17)

1. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W., Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 Science 1997 275 5304 1320 1323 (Pubitemid 27114163)
2. Okegawa T., Pong R. C., Li Y., Bergelson J. M., Sagalowsky A. I., Hsieh J. T., The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure Cancer Research 2001 61 17 6592 6600 (Pubitemid 32783269)
3. Okegawa T., Li Y., Pong R. C., Bergelson J. M., Zhou J., Hsieh J. T., The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy Cancer Research 2000 60 18 5031 5036
4. Zhang L. L., He D. L., Li X., Li L., Zhu G. D., Zhang D., Wang X. Y., Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo Acta Pharmacologica Sinica 2007 28 6 895 900 (Pubitemid 46817440)
5. Kim M., Sumerel L. A., Belousova N., Lyons G. R., Carey D. E., Krasnykh V., Douglas J. T., The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells British Journal of Cancer 2003 88 9 1411 1416 (Pubitemid 36606425)
6. Stecker K., Koschel A., Wiedenmann B., Anders M., Loss of Coxsackie and adenovirus receptor downregulates -catenin expression British Journal of Cancer 2009 101 9 1574 1579
7. Anders M., Vieth M., Rcken C., Ebert M., Pross M., Gretschel S., Schlag P. M., Wiedenmann B., Kemmner W., Hcker M., Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression British Journal of Cancer 2009 100 2 352 359
8. Pong R. C., Lai Y. J., Chen H., Okegawa T., Frenkel E., Sagalowsky A., Hsieh J. T., Epigenetic Regulation of Coxsackie and Adenovirus Receptor (CAR) gene promoter in urogenital cancer cells Cancer Research 2003 63 24 8680 8686 (Pubitemid 38064044)
9. Sachs M. D., Ramamurthy M., Van Der Poel H., Wickham T. J., Lamfers M., Gerritsen W., Chowdhury W., Li Y., Schoenberg M. P., Rodriguez R., Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells Cancer Gene Therapy 2004 11 7 477 486 (Pubitemid 38902674)
10. Anders M., Christian C., McMahon M., McCormick F., Korn W. M., Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells Cancer Research 2003 63 9 2088 2095 (Pubitemid 36538611)
11. Lim J. Y., Won H. K., Kim J., Sang I. P., Induction of Id2 expression by cardiac transcription factors GATA4 and Nkx2.5 Journal of Cellular Biochemistry 2008 103 1 182 194
12. Blume S. W., Snyder R. C., Ray R., Thomas S., Koller C. A., Miller D. M., Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo Journal of Clinical Investigation 1991 88 5 1613 1621
13. Greenwel P., Inagaki Y., Hu W., Walsh M., Ramirez F., Sp1 is required for the early response of 2(I) collagen to transforming growth factor- 1 Journal of Biological Chemistry 1997 272 32 19738 19745 (Pubitemid 27340064)
14. Ray R., Snyder R. C., Thomas S., Koller C. A., Miller D. M., Mithramycin blocks protein binding and function of the SV40 early promoter Journal of Clinical Investigation 1989 83 6 2003 2007 (Pubitemid 19148872)
15. Kitazono M., Goldsmith M. E., Aikou T., Bates S., Fojo T., Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228 Cancer Research 2001 61 17 6328 6330 (Pubitemid 32783231)
16. Kitazono M., Rao V. K., Robey R., Aikou T., Bates S., Fojo T., Goldsmith M. E., Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells Blood 2002 99 6 2248 2251 (Pubitemid 34525515)
17. Goldsmith M. E., Kitazono M., Fok P., Aikou T., Bates S., Fojo T., The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells Clinical Cancer Research 2003 9 14 5394 5401 (Pubitemid 37413595)